Chemomab Therapeutics Ltd. (CMMB) › Operating IncomeChemomab Therapeutics Ltd. (CMMB) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2024: -$103.00M2025: -$112.00M-$112.00M2024Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$112.00M-8.7%2024-$103.00M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share